Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

February 15, 2006 (Vol. 26, No. 4)

Capitalizing on Biotech Production Opportunities

Supporting Growth in the Sector by Providing a Favorable Environment

  • Up to 30 new biopharmaceuticals being developed in Britain could be approved over the next seven years, according to the U.K. national bioprocessing network, bioProcess U.K. The new data, gathered by the organization, were revealed at the second Annual bioProcess U.K. Forum, recently held in Liverpool. Over 50 U.K. ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.